Efficient inhibition of uveal melanoma via ternary siRNA complexes
Document Type
Article
Date of Original Version
1-5-2020
Abstract
Uveal melanoma (UM) is rare yet the most common and malignant primary intraocular tumor in adults. Due to the lack of effective treatment, the mortality rate of UM has remained high over the past few decades. In the present study, hyaluronic acid (HA) coated chitosan (Chi)/siRNA ternary complexes have been developed and characterized as a novel therapeutic strategy molecularly targeting hypoxia-inducible factor 1α (HIF-1α) pathway for the treatment of UM. The cytotoxicity, cellular uptake, and siRNA silencing effect of the developed siRNA complexes were evaluated. In addition, whether the developed ternary complexes can inhibit UM migration and invasion was investigated. Results showed that the developed ternary siRNA complexes were negatively charged and with a particle size below 190 nm. The ternary siRNA complexes showed excellent cellular uptake and lysosome escape ability with low cytotoxicity. In addition, the ternary complexes were able to downregulate both HIF-1α and VEGF expression in UM cells, and successfully inhibit UM migration and invasion. These results demonstrated that the biocompatible ternary siRNA complexes are promising for local treatment of UM in the posterior segment with future clinical application potential.
Publication Title, e.g., Journal
International Journal of Pharmaceutics
Volume
573
Citation/Publisher Attribution
Xie, Lingxiao, Yan Yang, and Jie Shen. "Efficient inhibition of uveal melanoma via ternary siRNA complexes." International Journal of Pharmaceutics 573, (2020). doi: 10.1016/j.ijpharm.2019.118894.